NewsBenzinga美国食品和药物管理局（FDA）接受了英斯梅德公司的新药补充申请，用于审评Arikayce（阿米卡星脂质体吸入悬浮液）作为结核分枝杆菌复合肺病的一部分的联合抗菌药疗法，目标行动日期为2027年1月28日。 美国食品和药物管理局（FDA）接受了英斯梅德公司的新药补充申请，用于审评Arikayce（阿米卡星脂质体吸入悬浮液）作为结核分枝杆菌复合肺病的一部分的联合抗菌药疗法，目标行动日期为2027年1月28日。 Benzinga 2026.09.21 11:10 (GMT+0) Open on Benzinga Other news Jones Trading Maintains Buy on Dynex Cap, Lowers Price Target to $12.5 Here's How Much $100 Invested In Gartner 20 Years Ago Would Be Worth Today Microsoft says AI agents are like insider threats as ‘frontier models can’t be trusted’ Dorchester Minerals Enters Into An Agreement To Acquire Mineral And Royalty Interests; To Buy ~ 4,300 Net Royalty Acres In Williston Basin, North Dakota; Interests To Be Exchanged For 1,250,000 Common Units Of Dorchester Minerals Here's How Much $100 Invested In Fastenal 10 Years Ago Would Be Worth Today Bernstein Just Upgraded Datadog Stock. Here's Why.
Dorchester Minerals Enters Into An Agreement To Acquire Mineral And Royalty Interests; To Buy ~ 4,300 Net Royalty Acres In Williston Basin, North Dakota; Interests To Be Exchanged For 1,250,000 Common Units Of Dorchester Minerals
